866-997-4948(US-Canada Toll Free)

CARDIONOVUM GmbH - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 25 Pages


CARDIONOVUM GmbH (Cardionovum) is a medical device company. It carries out the design, development, manufacture and distribution of coronary vascular intervention and peripheral vascular intervention products. Its major products include paclitaxel-eluting coronary PTCA catheter, Sirolimus-eluting coronary stent system, cobalt chromium coronary stent system, protective coronary stenting therapy system and paclitaxel-eluting peripheral PTCA catheter. It has a subsidiary in Poland, namely, CARDIONOVUM Sp.z.o.o. The company is headquartered in Bonn, Germany.

Cardionovum seeks to develop clinically advanced medical therapies, which take off from the current patient treatment standard by conventional balloon catheters and stent designs. The company envisages manufacturing the best possible products to minimize complication rates and to offer medical devices which ensure rapid healing for the benefit of patients.

This report is a source for data, analysis and actionable intelligence on the CARDIONOVUM GmbH portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
CARDIONOVUM GmbH - Major Products and Services 5
CARDIONOVUM GmbH Pipeline Products by Equipment Type 6
CARDIONOVUM GmbH Pipeline Products by Development Stage 8
CARDIONOVUM GmbH Pipeline Products by Therapy Area 10
CARDIONOVUM GmbH Pipeline Products by Trial Phase 12
CARDIONOVUM GmbH Pipeline Products by Milestone Summary 14
PROLIMUS Biograde 16
PROLIMUS Biograde Product Status 16
PROLIMUS Biograde Product Description 16
PROLIMUS Biograde Product Milestone 16
RESORB 18
RESORB Product Status 18
RESORB Product Description 18
RESTORE Drug Eluting Balloon 19
RESTORE Drug Eluting Balloon Product Status 19
RESTORE Drug Eluting Balloon Product Description 19
RESTORE Drug Eluting Balloon Product Milestone 19
RESTORE Drug Eluting Balloon Clinical Trial 20
CARDIONOVUM GmbH - Key Competitors 21
CARDIONOVUM GmbH - Key Employees 22
CARDIONOVUM GmbH - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
CARDIONOVUM GmbH, Recent Developments 24
Oct 09, 2012: Cardionovum To Begin Commercialization Of DCB And DES Products Outside US 24
May 10, 2012: Cardionovum To Launch Two DEB Dilatation Catheter Product Families At EuroPCR 2012 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Table

List of Tables
CARDIONOVUM GmbH, Key Facts 1
CARDIONOVUM GmbH Key Pipeline Products by Equipment Type 1
CARDIONOVUM GmbH Key Pipeline Products by Therapy Area 1
CARDIONOVUM GmbH Key Pipeline Products by Development Stage 1
CARDIONOVUM GmbH Key Pipeline Products by Trial Phase 1
CARDIONOVUM GmbH, Key Facts 4
CARDIONOVUM GmbH, Major Products and Services 5
CARDIONOVUM GmbH Number of Pipeline Products by Equipment Type 6
CARDIONOVUM GmbH Pipeline Products by Equipment Type 7
CARDIONOVUM GmbH Number of Pipeline Products by Development Stage 8
CARDIONOVUM GmbH Pipeline Products by Development Stage 9
CARDIONOVUM GmbH Number of Pipeline Products by Therapy Area 10
CARDIONOVUM GmbH Pipeline Products by Therapy Area 11
CARDIONOVUM GmbH Number of Pipeline Products by Trial Phase 12
CARDIONOVUM GmbH Pipeline Products by Trial Phase 13
CARDIONOVUM GmbH Number of Pipeline Products By Milestone Summary 14
CARDIONOVUM GmbH Pipeline Products by Milestone Summary 15
PROLIMUS Biograde - Product Status 16
PROLIMUS Biograde - Product Description 16
PROLIMUS Biograde - Product Milestone 16
RESORB - Product Status 18
RESORB - Product Description 18
RESTORE Drug Eluting Balloon - Product Status 19
RESTORE Drug Eluting Balloon - Product Description 19
RESTORE Drug Eluting Balloon - Product Milestone 19
RESTORE Drug Eluting Balloon - A Clinical Study Designed to Increase Drug-in-tissue Concentration Using RESTORE Drug-Eluting Balloon (DEB) 20
CARDIONOVUM GmbH, Key Employees 22
CARDIONOVUM GmbH, Subsidiaries 23

List of Chart

List of Figures
CARDIONOVUM GmbH Pipeline Products by Equipment Type 6
CARDIONOVUM GmbH Pipeline Products by Development Stage 8
CARDIONOVUM GmbH Pipeline Products by Therapy Area 10
CARDIONOVUM GmbH Pipeline Products by Trial Phase 12
CARDIONOVUM GmbH Pipeline Products by Milestone Summary 14

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *